Lake Street Maintains Buy on Rapid Micro Biosystems, Lowers Price Target to $7

Benzinga Newsdesk www.benzinga.com Negative 59.1%

Neg 59.1% Neu 0% Pos 0%

Lake Street analyst Thomas Flaten maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Buy and lowers the price target from $8 to $7.